Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 2 | BMC Musculoskeletal Disorders

Figure 2

From: Endostatin inhibits VEGF-A induced osteoclastic bone resorption in vitro

Figure 2

Typical appearance of the bone slices in the pit assay. Rat bone cells were cultured on bovine bone slices with different treatments. After 48 hours, cells were wiped off and resorbed bone area was visualized with image analyzer system. Bone slices after (A) Control (B) VEGF-A 10 ng/ml (C) VEGF-A 50 ng/ml (D) VEGF-A 100 ng/ml (E) Endostatin 0.02 μg/ml (F) Endostatin 0.2 μg/ml (G) Endostatin 2 μg/ml (H) VEGF-A 10 ng/ml and Endostatin 0.02 μg/ml (I) VEGF-A 50 ng/ml and Endostatin 0.2 μg/ml (J) VEGF-A 100 ng/ml and Endostatin 2 μg/ml treatments. Scale bar 100 μm.

Back to article page